Recombinant human interleukin-11 does not modify biochemical parameters of bone remodeling and bone mineral density in adult ovariectomized rats

Journal of Interferon and Cytokine Research

Volumn 18, Issue 1, 1998, Pages 49-53

  Verhaeghe, J ^a,c   Van Herck, E ^a   Van Bree, R ^a   Bouillon, R ^a   Dequeker, J ^a   Keith Jr , J C ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b PFIZER INC   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; PYRIDINOLINE; RECOMBINANT INTERLEUKIN 11;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; FLUID INTAKE; METAPHYSIS; NONHUMAN; OSTEOBLAST; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION; URINE VOLUME;

ANIMALIA;

EID: 0031930705     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.49     Document Type: Article

References (26)

1. MANOLAGAS, S.C., and JILKA, R.L. (1995). Bone marrow, cytokines, and remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332, 305-311.
2. KIMBLE, R.B., MATAYOSHI, A.B., VANNICE, J.L., KUNG, V.T., WILLIAMS, C., and PACIFICI, R. (1995). Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136, 3054-3061.
3. AMMANN, P., RIZZOLI, R., BONJOUR, J.-P., BOURRIN, S., MEYER, J.-M., VASSALLI, P., and GARCIA, I. (1997). Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99, 1699-1703.
4. PAUL, S.R., BENNETT, F., CALVETTI, J.A., KELLEHER, K., WOOD, C.R., O'HARA, R.M., LEARY, A.C., SIBLEY, B., CLARK, S.C., WILLIAMS, D.A., and YANG, Y.-C. (1990). Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic cytokine. Proc. Natl. Acad. Sci. USA 87, 7512-7516.
5. GOLDMAN, S.J. 1995). Preclinical biology of interleukin 11: a multifunctional cytokine with potent thrombopoietic activity. Stem Cells 13, 462-471.
6. TEPLER, I., ELIAS, L., SMITH, J.W., HUSSEIN, M., ROSEN, G., CHANG, A.Y.-C., MOORE, J.O., GORDON, M.S., K,UCA, B., BEACH, K.J., LOEWY, J.W., GARNICK, M.B., and KAYE, J.A. (1996). A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87, 3607-3614.
7. GORDON, M.S., McCASKILL-STEVENS, W.J., BATTIATO, L.A., LOEWY, J., LOESCH, D., BREEDEN, E., HOFFMAN, R., BEACH, K.J., KUCA, B., KAYE, J., and SLEDGE G.W. (1996). A phase I trial of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87, 3615-3624.
8. ELIAS, J.A., TANG, W., and HOROWITZ, M.C. (1995). Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136, 489-498.
9. ROMAS, E., UDAGAWA, N., ZHOU, H., TAMURA, T., SAITO, M., TAGA, T., HILTON, D.J., SUDA, T., NG, K.W., and MARTIN, T.J. (1996). The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. 183, 2581-2591.
10. BELLIDO, T., STAHL, N., FARRUGELLA, T.J., BORBA, V., YANCOPOULOS, G.D., and MANOLAGAS, S.C. (1996). Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J. Clin. Invest. 9, 431-137.
11. HUGHES, F.J., and HOWELLS, G.L. (1993). Interleukin-11 inhibits bone formation in vitro. Calcif. Tissue Int. 53, 362-364.
12. GIRASOLE, G., PASSERI, G., JILKA, R.L., and MANOLAGAS, S.C. (1994). Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest. 93, 1516-1524.
13. DEMPSTER, D.W., BIRCHMAN, R., XU, R., LINDSAY, R., and SHEN, V. (1995). Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16, 157-161.
14. YONEMURA, Y., KAWATIKA, M., MASUDA, T., FUJIMOTO, K., and TAKATSUKI, K. (1993). Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6. Br. J. Haematol. 84, 16-23.
15. VERHAEGHE, J., VAN HERCK, E., VAN BREE, R., and BOUILLON, R. (1995). Effects of IGF-I, alone and in combination with 17β-oestradiol, on bone remodelling parameters in ovariectomised rats. Growth Regul. 5, 210-217.
16. VERHAEGHE, J., VAN HERCK, E., VAN BREE, R., VAN ASSCHE, F.A., and BOUILLON, R. (1989). Osteocalcin during the reproductive cycle in normal and diabetic rats. J. Endocrinol. 120, 143-151.
17. VANDERSCHUEREN, D., JANS, I., VAN HERCK, E., MOERMANS, K., VERHAEGHE, J., and BOUILLON, R. (1994). Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. Bone Miner. 26, 123-131.
18. VANDERSCHUEREN, D., VAN HERCK, E., SCHOT, P., RUSH, E., EINHORN, T., GEUSENS, P., and BOUILLON, R. (1993). The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biochemical testing. Calcif. Tissue Int. 53, 342-347.
19. HAGIWARA, S., LANE, N., ENGELKE, K., SEBASTIAN, A., KIMMEL, D.B., and GENANT, H.K. (1993). Precision and accuracy for rat whole body and femur bone mineral determination with dual x-ray absorptiometry. Bone Miner. 22, 57-68.
20. ZEISLER, E.B. (1954). Determination of diffusible serum calcium. Am. J. Clin. Pathol. 24, 588-593.
21. YAMAURA, M. NAKAMURA, T., TSURUKAMI, H., HIJIOKA, A., NARUSAWA, K., OHNISHI, H., OHTA, T., and HOSODA, K. (1996). Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods of ovariectomy in rats. Calcif. Tissue int. 58, 52-59.
22. SHEN, V., BIRCHMAN, R., XU, R., LINDSAY, R., and DEMPSTER, D.W. (1995). Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium-deficient rats. Bone 16, 149-156.
23. SHEN, V., DEMPSTER, D.W., BIRCHMAN, R., XU, R., and LINDSAY, R. (1993). Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J. Clin. Invest. 91, 2479-2487.
24. AERSSENS, J., VAN AUDEKERCKE, R., GEUSENS, P., SCHOT, L.P.C., OSMAN, A.A.H., and DEQUEKER, J. (1993). Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment. Calcif. Tissue Int. 53, 269-277.
25. FERRETTI, J.L., CAPOZZA, R.F., MONDELO, N., and ZANCHETTA, J.R. (1993). Interrelationships between densitometric, geometric, and mechanical properties of rat femora: inferences concerning mechanical regulation of bone modeling. J. Bone Miner. Res. 8, 1389-1396.
26. KIM, G.S., KIM, C.H., CHOI, C.S., PARK, J.Y., and LEE, K.-U. (1997). Involvement of different second messengers in parathyroid hormone- and interleukin-1-induced interleukin-6 and interleukin-11 production in human bone marrow stromal cells. J. Bone Miner. Res. 12, 896-902.